{
  "ticker": "GILD",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T10:04:54.704574",
  "count": 110,
  "transactions": [
    {
      "id": 132717,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 132742,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 160578,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 160605,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 190813,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 190840,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 223404,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 223437,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 258671,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 258704,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 299085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 299123,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 344076,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 344120,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 391511,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 391556,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 132718,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 132731,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 132733,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 132741,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 132743,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 132745,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 160579,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 160593,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 160595,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 160604,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 160606,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 160608,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 190814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 190828,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 190830,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 190839,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 190841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 190843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 223406,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 223422,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 223424,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 223435,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 223439,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 223442,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 258673,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 258689,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 258691,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 258702,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 258706,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 258710,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 299088,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 299106,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 299109,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 299121,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 299125,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 299129,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 344081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 344101,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 344104,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 344118,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 344122,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 344126,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 391516,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 391537,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 391540,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 391554,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 391558,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 391562,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 132726,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 160587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 190822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 223415,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 258682,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 299097,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 344091,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 391527,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 106837,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 132747,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 160610,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 190845,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 223445,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 258713,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 299133,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 344130,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 391566,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 106842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 132752,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 160615,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 190852,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 223454,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 258723,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 299144,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 344141,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 391577,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 82894,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 106833,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 132739,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 160601,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 190836,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 223431,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 258698,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 299117,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 344114,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 391550,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 82890,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 106829,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 132735,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 160597,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 190832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 223426,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 258693,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 299111,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 344107,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 391543,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    }
  ]
}